Redeye briefly comments on Cinclus Pharma's announcement that the last patient has completed the fin...
Today Freemelt announced a new contract with Fusion for Energy (F4E) amounting to EUR 0.
Nokia has decided to discontinue its investment in the joint MoCA offering with InCoax and will remo...
Redeye comments on Senzime’s business and financial update.
Redeye analyst William Wällstedt gives a brief introduction to our newly initiated coverage of Smolt...
Elvenite's recent wins with TINE and Blentagruppen reinforce our positive H2 outlook for CombinedX.
Inderes raises its FY/26 guidance, driven by continued strong growth momentum within software.
Redeye comments on Better Collective’s updated guidance following the provisional nationwide ban on ...
Long overdue, Nanexa has finally signed a global, exclusive license and collaboration agreement with...
* New 12m SEK 90m order from a new US gov customer * SEK 84m SATCOM service, SEK 6m terminals * Key ...
*Holding renamed to AnchorCore SE, formalizing transformation *H1 sales +14.
*Q4 EBITDA reached € 88m, driven by ethanol spreads and GHG quota prices.
Redeye analyst Stefan Knutsson presents our newly initiated coverage of AddLife - what the company d...
Redeye comments on ExpreS2ion’s announcement of the outcome of the TO 13 warrant program.
Scanfil will arrange a CMD event on 29-30 September 2026.
* Q3e: 1% organic growth and 5% EBIT margin * The report should answer long-term questions * Trading...
BiBBInstruments announced this morning that it has received new orders for EndoDrill GI from its US ...
Redeye returns with an update following a review of BioArctic's pipeline and latest report.
Redeye comments on yesterday’s announcement that OncoZenge’s rights issue has concluded, with combin...
Bittium signed a two-year Memorandum of Understanding (MoU) with Safran Electronics & Defense to dev...